| 5872 |
Centers for Disease Control and Prevention |
Html |
en |
1,3-Butadiene - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 7079 |
Centers for Disease Control and Prevention |
Html |
en |
Global Health - Paraguay |
null |
| Content source | 0.422709 |
| HHS | 0.297574 |
| list Skip | 0.74332 |
| endorsement | 0.291872 |
| CDC | 0.271556 |
| non-federal site | 0.4688 |
|
| Notice | 0.270187 |
| sponsors | 0.241885 |
| page options Skip | 0.947337 |
| information | 0.241652 |
| employees | 0.242118 |
|
CLICK HERE |
| 8101 |
Centers for Disease Control and Prevention |
Html |
en |
MMWR News Synopsis: February 21, 2013 |
CDC Media Relations - MMWR News Synopsis: January 31, 2013 |
| public health toll | 0.417132 |
| 2012-2013 influenza vaccine | 0.613767 |
| Influenza activity | 0.494147 |
| individual states | 0.340435 |
| Extremely Premature Infants | 0.416294 |
| female breast | 0.414073 |
| pregnant women | 0.325027 |
| influenza antiviral medications | 0.608013 |
| vaccination status | 0.327366 |
| high risk patients | 0.42196 |
| percent-63 percent | 0.343964 |
| influenza vaccine | 0.698644 |
| United States | 0.912824 |
| greatest risk | 0.388798 |
| high cancer rates | 0.493059 |
| rectum cancer | 0.36328 |
| public health officials | 0.452968 |
| certain chronic conditions | 0.41557 |
| United States Cancer | 0.487256 |
| percent confidence | 0.340566 |
| incidence rates | 0.603048 |
| high risk | 0.429436 |
| primary DTaP series | 0.399393 |
| new cases | 0.336569 |
|
| cancer prevention | 0.369152 |
| highest hospitalization rate | 0.398874 |
| cancer registry data | 0.694568 |
| maternal pertussis antibodies | 0.466195 |
| recent influenza seasons | 0.589464 |
| Electronic Media | 0.713097 |
| national cancer objectives | 0.477617 |
| important protection | 0.324771 |
| influenza B viruses | 0.495106 |
| government cancer incidence | 0.505836 |
| public health value | 0.428207 |
| Healthy People | 0.341745 |
| early antiviral treatment | 0.437634 |
| public health | 0.562673 |
| CDC
Division | 0.361401 |
| Zinc Deficiency Dermatitis | 0.401619 |
| influenza season | 0.592642 |
| National cancer registry | 0.694636 |
| cancer incidence rates | 0.515648 |
| annual incidence rate | 0.4876 |
| influenza vaccination | 0.504304 |
| prolonged illness. Infants | 0.419104 |
| influenza complications | 0.511444 |
| influenza vaccine effectiveness | 0.614979 |
|
CLICK HERE |
| 8481 |
Centers for Disease Control and Prevention |
Html |
en |
Tiffany's Biography - Tiffany's Story - Real Stories - Tips from Former Smokers - Smoking & Tobacco Use |
The biography of Tiffany, a former smoker who successfully quit smoking and who is featured in CDC's Tips from Former Smokers campaign. |
| instructions | 0.43717 |
| social events | 0.591639 |
| death | 0.437569 |
| stamina | 0.445435 |
| cigarette smoker | 0.622531 |
| ashtrays | 0.445443 |
| effort | 0.436898 |
| enduring motivation | 0.582777 |
| cough | 0.452454 |
| previous attempts | 0.576972 |
| life | 0.437181 |
| lung cancer | 0.802681 |
| cigarette smoking | 0.621049 |
| sleep | 0.436974 |
| mother | 0.644914 |
| specific date | 0.593264 |
| suffer | 0.447379 |
| times | 0.436797 |
| school | 0.439979 |
| car | 0.437807 |
| smoking | 0.656983 |
|
| connection | 0.439662 |
| kids | 0.440017 |
| energy | 0.437864 |
| cravings | 0.44555 |
| in. | 0.439886 |
| positive attitude | 0.579685 |
| late teens | 0.599842 |
| water | 0.439788 |
| friends | 0.479933 |
| picture | 0.43777 |
| home | 0.437825 |
| Tiffany | 0.937539 |
| morning ritual | 0.589538 |
| nicotine patch | 0.57742 |
| college scene | 0.599405 |
| coffee | 0.43944 |
| cigarettes | 0.630692 |
| time | 0.437235 |
| family | 0.479972 |
| daughter | 0.534716 |
| support | 0.479971 |
|
CLICK HERE |
| 10670 |
Centers for Disease Control and Prevention |
Html |
en |
Conjunctivitis: Home page |
Conjunctivitis (kuhn-juhngk-tuh-´vahy-tis) is an inflammation (swelling) or infection of the thin layer (conjunctiva) that lines the inside of the eyelid and covers the white part of the eye. Inflammation can cause blood vessels in the eye to become larger. And that can make the white of the eye look pink or red. Thus, conjunctivitis is often called pink eye or red eye. |
| symptoms | 0.62603 |
| itchy eyes | 0.818916 |
| medical treatment | 0.733447 |
| white | 0.63394 |
| red color | 0.797269 |
| adults | 0.557771 |
|
| People | 0.568669 |
| cause | 0.567102 |
| conjunctivitis | 0.722837 |
| redness | 0.561568 |
| pink eye | 0.987913 |
|
CLICK HERE |
| 10813 |
Centers for Disease Control and Prevention |
Html |
en |
MMWR News Synopsis: May 8, 2014 | CDC Media Relations | CDC |
MMWR – Morbidity and Mortality Weekly Report CDC public health news, press releases, government public health news, medical and disease news, story ideas, photos. |
| foreign-born persons | 0.552259 |
| effective model | 0.540633 |
| community-based sites | 0.5424 |
| New York City | 0.829663 |
| primary care providers | 0.687156 |
| San Diego | 0.638676 |
| provider expertise | 0.554703 |
| Hepatitis B virus | 0.552674 |
| secondary syphilis cases | 0.710532 |
| National Center | 0.832078 |
| TB Prevention | 0.850973 |
| Viral Hepatitis | 0.846144 |
| weekly sessions | 0.543746 |
| patient navigation activities | 0.630671 |
| patient management practices | 0.658362 |
| primary care clinicians | 0.685362 |
| chronic HBV infection | 0.735623 |
| persons | 0.592405 |
| HBV testing initiatives | 0.720876 |
| refugee clinics | 0.53978 |
| higher HBV prevalence | 0.715743 |
| primary care capacity | 0.895055 |
| HCV treatment | 0.666618 |
| limited access | 0.55457 |
| community-based testing | 0.546544 |
|
| HCV infection | 0.773144 |
| newly arriving refugees | 0.639606 |
| percent | 0.758746 |
| HCV testing | 0.672793 |
| Project ECHO | 0.541765 |
| community-based settings | 0.543328 |
| tremendous progress | 0.55035 |
| community-based outreach | 0.541763 |
| hepatitis C virus | 0.571318 |
| videoconferencing software | 0.541539 |
| patient management | 0.689782 |
| MSM | 0.564614 |
| prior experience | 0.537394 |
| New surveillance data | 0.622963 |
| significant barriers | 0.545081 |
| sex partner data | 0.617675 |
| racial/ethnic minorities | 0.543031 |
| medical care | 0.787021 |
| antiviral treatment | 0.546584 |
| Innovative efforts | 0.545139 |
| public health benefits | 0.679523 |
| primary care | 0.905613 |
| HCV specialists | 0.646536 |
| HCV diagnosis | 0.646491 |
|
CLICK HERE |
| 12776 |
Centers for Disease Control and Prevention |
Html |
en |
Implementation of a Statewide Surveillance System forNeonatal Abstinence Syndrome - Tennessee, 2013 |
Michael D. Warren, MD1, Angela M. Miller, PhD1, Julie Traylor, MPH1, Audrey Bauer, DVM1, Stephen W. |
| NAS | 0.999618 |
| Weekly surveillance reports | 0.458179 |
| neonatal drug tests | 0.451426 |
| health care provider | 0.840464 |
| neonatal drug screen | 0.44498 |
| maternal exposure source | 0.467944 |
| clinical withdrawal syndrome | 0.457842 |
| unintended pregnancy | 0.446461 |
| commonly reported sources | 0.454398 |
| health care providers | 0.723771 |
| opioid pain relievers | 0.666196 |
| surveillance data | 0.464332 |
| timelier incidence figures | 0.453862 |
| Stephen W. Patrick | 0.451776 |
| various public health | 0.470527 |
| incidence rate | 0.445395 |
| Public health partners | 0.469854 |
| prescription drug monitoring | 0.548397 |
| state prescription drug | 0.446041 |
| TDH staff | 0.481931 |
| live births | 0.448514 |
| high NAS incidence | 0.62265 |
| female opioid users | 0.520473 |
| additional reporting burden | 0.457882 |
|
| opioid dependency | 0.4561 |
| Michael D. Warren | 0.568233 |
| NAS cases | 0.700216 |
| NAS reporting | 0.594031 |
| previous population-based analyses | 0.55981 |
| public health staff | 0.477239 |
| MMWR
Michael D. | 0.450972 |
| local health department | 0.46244 |
| Angela M. Miller | 0.44832 |
| eastern Tennessee | 0.522627 |
| public health burden | 0.486871 |
| state health department | 0.477118 |
| primary prevention | 0.487468 |
| reporting hospital | 0.444516 |
| public health stakeholders | 0.584974 |
| public health | 0.615984 |
| clinical signs | 0.515589 |
| Tennessee NAS surveillance | 0.65904 |
| hospital discharge data | 0.795734 |
| rural primary care | 0.443761 |
| eastern Tennessee counties | 0.455608 |
| adverse outcomes | 0.445302 |
| neonatal abstinence syndrome | 0.469929 |
| opioid pain reliever | 0.542295 |
|
CLICK HERE |
| 12993 |
Centers for Disease Control and Prevention |
Html |
en |
Vaccines: ACIP Vaccine Recommendations - Pneumococcal -CDC |
ACIP Recommendations on Pneumococcal vaccine and other MMWR articles. Advisory Committee on Immunization Practices (ACIP) |
| Vaccine Shortage Resolved | 0.555258 |
| Intervals | 0.410353 |
| CDC Director | 0.446756 |
| Pneumococcal Disease | 0.439203 |
| Print version | 0.95457 |
| Mortality Weekly Report | 0.49169 |
| Cochlear Implant Recipients | 0.547067 |
| United States | 0.451452 |
| Pneumococcal Conjugate Vaccine | 0.780754 |
| advice | 0.410451 |
| adults | 0.409487 |
| Moore MR | 0.495184 |
| recommendations | 0.559227 |
| Cochlear Implant | 0.573026 |
| related agents | 0.451596 |
| Stoecker | 0.409551 |
| Pneumococcal Vaccination | 0.547197 |
| Immunization Practices | 0.493449 |
| Whitney CG | 0.499626 |
| Advisory Committee | 0.491758 |
| pages | 0.658157 |
| Notice | 0.475129 |
| Gierke | 0.42124 |
| Reinstatement | 0.40959 |
|
| ACIP | 0.551964 |
| Conjugate Vaccine Shortage | 0.558306 |
| civilian population | 0.449827 |
| catch-up table | 0.440887 |
| Dose | 0.419648 |
| official CDC/HHS recommendations | 0.50055 |
| MMWR | 0.668377 |
| Cochlear Implant Candidates | 0.547845 |
| Tomczyk | 0.409564 |
| PCV13 | 0.420536 |
| PPSV-23 vaccine | 0.451421 |
| PPSV23 vaccines | 0.448887 |
| 13-Valent Pneumococcal Conjugate | 0.486138 |
| Almendares | 0.41025 |
| Kobayashi | 0.410814 |
| control | 0.410413 |
| Readers | 0.466701 |
| Morbidity | 0.411046 |
| Vol | 0.656029 |
| Bennett NM | 0.498368 |
| MMWR. | 0.422591 |
| PCV-13 | 0.409497 |
| et al | 0.496799 |
|
CLICK HERE |
| 15313 |
Centers for Disease Control and Prevention |
Html |
en |
Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky Mountain Spotted Fever and Other Spotted Fever Group Rickettsioses, Ehrlichioses, and Anaplasmosis - United States |
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). |
| Rickettsial Zoonoses Branch | 0.450508 |
| tick species | 0.389676 |
| SFG rickettsiosis | 0.372136 |
| tick exposure | 0.384677 |
| average annual incidence | 0.403409 |
| tickborne relapsing fever | 0.381634 |
| tickborne rickettsial diseases | 0.926621 |
| tickborne rickettsioses | 0.380739 |
| tickborne rickettsial pathogens | 0.51761 |
| health care providers | 0.664241 |
| R. parkeri | 0.376578 |
| tickborne rickettsial infection | 0.468762 |
| tickborne rickettsial illnesses | 0.47109 |
| patients | 0.400423 |
| tickborne rickettsial disease | 0.621932 |
| ehrlichiosis | 0.426332 |
| E. chaffeensis ehrlichiosis | 0.416157 |
| human monocytic ehrlichiosis | 0.411977 |
| R. rickettsii | 0.37921 |
| persons | 0.37852 |
| A. phagocytophilum | 0.380528 |
| human tickborne disease | 0.396353 |
| nontickborne rickettsial illnesses | 0.387916 |
| passive surveillance | 0.385427 |
|
| rickettsial disease overlap | 0.383525 |
| different tick vectors | 0.383237 |
| United States | 0.780383 |
| rickettsial laboratory diagnostics | 0.387694 |
| Rickettsia species 364D | 0.381679 |
| tick season | 0.387431 |
| confirmatory diagnostic tests | 0.37168 |
| tickborne rickettsial infections | 0.455168 |
| E. chaffeensis | 0.49299 |
| past rickettsial infection | 0.379208 |
| public health professionals | 0.387544 |
| public health | 0.391605 |
| cases | 0.421171 |
| ticks | 0.397276 |
| RMSF | 0.425196 |
| human tick exposure | 0.371772 |
| Ehrlichia chaffeensis ehrlichiosis | 0.372341 |
| tickborne illness | 0.378069 |
| Figure | 0.37995 |
| tick bite | 0.40098 |
| fatal rickettsial illness | 0.381305 |
| lone star | 0.391248 |
| Rickettsia species | 0.417417 |
| tickborne viral infection | 0.379713 |
|
CLICK HERE |
| 15780 |
Centers for Disease Control and Prevention |
Html |
en |
CDC Zika Interim Response Plan | Zika virus | CDC |
Information on Zika virus. Provided by the U.S. Centers for Disease Control and Prevention. |
| Building | 0.422793 |
| United States | 0.680508 |
| purpose | 0.451666 |
| document | 0.479673 |
| freely associated states | 0.660543 |
| Zika virus | 0.94271 |
| critical guidance | 0.616972 |
| areas | 0.422864 |
| Zika virus infection | 0.730923 |
| response activities | 0.528358 |
| Information | 0.425084 |
| continental United States | 0.677349 |
| reference | 0.424523 |
| pregnant women | 0.684864 |
| CDC Zika Interim | 0.668026 |
| tribal jurisdictions | 0.585269 |
| decisions | 0.423468 |
| local health partners | 0.628439 |
| available knowledge | 0.537126 |
|
| public health decision-making | 0.655423 |
| Detailed guidance | 0.625888 |
| Response Plan | 0.524123 |
| Zika virus infections | 0.697943 |
| infants | 0.462085 |
| cases | 0.42775 |
| Hawaii | 0.427641 |
| Zika virus disease | 0.724587 |
| resources | 0.42779 |
| blood | 0.4228 |
| previous versions | 0.532645 |
| effects | 0.423877 |
| tissue safety | 0.529214 |
| territories | 0.42732 |
| guidance | 0.755202 |
| Zika active transmission | 0.64512 |
| risk | 0.422846 |
| testing guidance | 0.618773 |
| communities | 0.427134 |
|
CLICK HERE |